MetLife Investment Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $58.4K | Sell |
2,205
-4,331
| -66% | -$115K | ﹤0.01% | 2675 |
|
2025
Q1 | $158K | Sell |
6,536
-14
| -0.2% | -$338 | ﹤0.01% | 2316 |
|
2024
Q4 | $264K | Sell |
6,550
-79
| -1% | -$3.18K | ﹤0.01% | 2158 |
|
2024
Q3 | $420K | Sell |
6,629
-130
| -2% | -$8.23K | ﹤0.01% | 1875 |
|
2024
Q2 | $358K | Sell |
6,759
-45,439
| -87% | -$2.41M | ﹤0.01% | 1912 |
|
2024
Q1 | $4.28M | Buy |
52,198
+1,501
| +3% | +$123K | 0.03% | 577 |
|
2023
Q4 | $943K | Hold |
50,697
| – | – | 0.01% | 1326 |
|
2023
Q3 | $561K | Hold |
50,697
| – | – | ﹤0.01% | 1556 |
|
2023
Q2 | $822K | Buy |
+50,697
| New | +$822K | 0.01% | 1377 |
|
2022
Q2 | – | Sell |
-7,040
| Closed | -$21.1K | – | 2908 |
|
2022
Q1 | $21.1K | Sell |
7,040
-19,437
| -73% | -$58.3K | ﹤0.01% | 2708 |
|
2021
Q4 | $122K | Buy |
26,477
+11,454
| +76% | +$52.7K | ﹤0.01% | 2332 |
|
2021
Q3 | $94.3K | Sell |
15,023
-12,499
| -45% | -$78.5K | ﹤0.01% | 2464 |
|
2021
Q2 | $165K | Buy |
27,522
+18,376
| +201% | +$110K | ﹤0.01% | 2270 |
|
2021
Q1 | $57.8K | Sell |
9,146
-20,668
| -69% | -$131K | ﹤0.01% | 2279 |
|
2020
Q4 | $168K | Buy |
29,814
+1,212
| +4% | +$6.82K | ﹤0.01% | 2074 |
|
2020
Q3 | $166K | Hold |
28,602
| – | – | ﹤0.01% | 1970 |
|
2020
Q2 | $206K | Hold |
28,602
| – | – | ﹤0.01% | 1887 |
|
2020
Q1 | $134K | Hold |
28,602
| – | – | ﹤0.01% | 1920 |
|
2019
Q4 | $229K | Hold |
28,602
| – | – | ﹤0.01% | 1906 |
|
2019
Q3 | $197K | Hold |
28,602
| – | – | ﹤0.01% | 1958 |
|
2019
Q2 | $237K | Hold |
28,602
| – | – | ﹤0.01% | 1927 |
|
2019
Q1 | $284K | Hold |
28,602
| – | – | ﹤0.01% | 1779 |
|
2018
Q4 | $219K | Buy |
28,602
+6,905
| +32% | +$52.8K | ﹤0.01% | 1858 |
|
2018
Q3 | $378K | Hold |
21,697
| – | – | ﹤0.01% | 1713 |
|
2018
Q2 | $206K | Buy |
+21,697
| New | +$206K | ﹤0.01% | 1908 |
|